Dual Certification in Peptide Therapy

INSTRUCTORS AND CONTRIBUTORS

Dr Christopher Maclay MBBS, FRACGP (Ret.) Dr Christopher Maclay is a Health Expert and retired Medical Practitioner. A leading advocate and strategist in peptide therapy across Australia and the United States. He is the Academic Director of the Institute and the creator of the F.A.R.M. (Functional, Anti-Aging & Regenerative Medicine) system for improving clinical outcomes. Dr Maclay has collaborated with industry leaders internationally and is acutely aware of the risk environments faced by patients and clinicians, with a strong focus on governance, safety, and compliant access to emerging therapies. Dr Richard Goldfarb, MD, FACS Dr Richard Goldfarb is a board-certified surgeon who utilizes non-surgical and surgical techniques to treat the signs of aging. At Melora Health & Enhancement, a medical spa in Downingtown, Pennsylvania. Dr. Goldfarb uses cutting-edge technology to eliminate unwanted fat, build muscle, reduce wrinkles without extensive downtime. With over 30 years of experience, Dr. Goldfarb is sought after pioneer in the field of Aesthetics. Dr. Goldfarb earned his medical degree with top honors from Chicago Medical School in Chicago, Illinois. His surgical residency consisted of Cooper University in Camden, New Jersey and Jackson Memorial Hospital for Trauma. He continued his training at Akron General Medical Center of the Cleveland Clinic. He trained in Telesurgery at Yale University in New Haven, Connecticut. Dr. Goldfarb completed plastic surgery training at the University of Pennsylvania, Department of Plastic Surgery. Professor Lee Kennedy MBBS, FRACP, PhD Professor Lee Kennedy is a Fellow of the Royal Australasian College of Physicians, specialist endocrinologist, and Associate Professor of Medicine at Monash University. He is actively engaged in research, publishing, and academic leadership within the Australian peptide and metabolic medicine ecosystem. Professor Kennedy is committed to advancing the safe, evidence-based, and compliant use of emerging therapies to improve patient outcomes. Dr Mark Lewis BPharm, MBBS Dr Mark Lewis is both a qualified pharmacist and medical practitioner, deeply involved in the Australian therapeutic peptide landscape. With experience in prescribing, monitoring, and integrating peptide-based interventions, he brings a unique dual-disciplinary perspective to patient safety, pharmacology, and clinical optimisation in emerging therapies. Dr Zac Turner, MBBS, RN Dr. Zac Turner is a medical doctor who brings a diverse and practical healthcare background to the Institute of Emerging Therapies. Prior to medicine, he trained and worked as a Registered Nurse in Australia and internationally, and he is an officer of the Royal Australian Navy. Dr. Zac has broad surgical experience across orthopaedics, plastics, and reconstructive surgery, and holds a strong interest in sports medicine, preventative health, bespoke vitality and longevity programs, medication formulation, and aesthetics. Dr Silvina Frick MD Dr Silvina Frick is an Argentinian family physician with a strong academic interest in research, clinical education, and translational science. She contributes extensive experience in evaluating scientific evidence for innovative and emerging therapeutic indications, ensuring that clinical content remains rigorous, relevant, and of high educational quality. Justin Kirkland MSc Justin Kirkland is a U.S.-based peptide chemist, formulation scientist, and research consultant with extensive experience in therapeutic peptide design, analytical chemistry, and GMP/GLP manufacturing environments. He has contributed to multiple commercial and research-grade peptide development programs and provides scientific oversight on quality, stability, and translational application of novel peptide compounds.